Skip to main content
OpenTrials

Clinical trial condition

Stage IA2 Endometrial Cancer FIGO 2023

Explore clinical trials studying Stage IA2 Endometrial Cancer FIGO 2023. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Stage IA2 Endometrial Cancer FIGO 2023 trial results

Recruiting

Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study

NCT06689956

Conditions
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Stage IA1 Endometrial Cancer FIGO 2023, +1 more
Locations
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Houston Methodist Hospital Houston, Texas, United States
  • Medical University of Vienna Vienna, Austria
View all 20 locations
View Trial Details

Related conditions